Longitudinal psychometric attributes, responsiveness, and importance of change:: An approach using the SCOPA-Psychosocial Questionnaire

被引:12
作者
Martinez-Martin, Pablo [1 ]
Javier Carod-Artal, Francisco [2 ]
da Sltveira Ribeiro, Luciola [2 ]
Ziomkowski, Sofia [2 ]
Pedro Vargas, Antonio [2 ]
Kummer, Wladimir [2 ]
Mourao Mesquita, Hudson [2 ]
机构
[1] Carlos III Inst Hlth, Natl Ctr Epidemiol, CIBERNED, Consortium Biomed Res Neurodegenerat Dis,Neuroepi, Madrid 28029, Spain
[2] Sarah Network Rehabil Hosp, Sarah Hosp, Dept Neurol, Brasilia, DF, Brazil
关键词
Parkinson's disease; SCOPA-Psychosocial; longitudinal validity; responsiveness; minimally important change;
D O I
10.1002/mds.22202
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The objective of this Study was to illustrate the analysis Of longitudinal validity. responsiveness, and importance Of change, using the SCOPA-Psychosocial Questionnaire (SCOPA-PS) as a source of empirical data. Sixty-seven patients with PD in Hoehn and Yahr (HY) stage 2 were followed LIP for I year and assessed by means of the Schwab and England Scale. Unified PD Rating Scale (UPDRS), Hospital Anxiety and Depression Scale (HADS), PDQ-39 and SCOPA-PS. A range of methods was applied to enable each of the target attributes to be analyzed front different conceptual stances. The SCOPA-PS displayed satisfactory acceptability (no floor or ceiling effect), internal consistency (alpha = 0.80-0.84), convergent validity (r(s) = 0.70-0.82 with PDQ-39), and precision (SEM = 8.80), both at baseline and at the end Of follow-up. The threshold value for significant change ranged from 17.25 (1.96 SEM) to 24.39 (Smallest real difference and Reliable change index). Threshold values for a clinically meaningful change were 0.73-1.26 (effect size, standardized response mean, responsiveness statistic). Change in SCOPA-PS scores correlated strongly with change in total UPDRS, HADS. and PDQ-39 scores, and reliably detected 70% of cases that worsened according to the PDQ-39. The minimally important change (MIC) for "minimally impaired" patients Is per the PDQ39 was 8.30-9.10 points. Indices Such as 1.96 SEM, effect size, and correlation with the change in other measures provide useful information about different concepts of responsiveness. The MIC should be determined for each specific setting, using distribution- and anchor-based methods. The SCOPA-PS showed satisfactory longitudinal attributes and responsiveness in stage-2 Brazilian patients with PD across 1 year of follow-up. (c) 2008 Movement Disorder Society.
引用
收藏
页码:1516 / 1523
页数:8
相关论文
共 59 条
[1]  
Aaronson N, 2002, QUAL LIFE RES, V11, P193
[2]   Sufficiently important difference: Expanding the framework of clinical significance [J].
Barrett, B ;
Brown, D ;
Mundt, M ;
Brown, R .
MEDICAL DECISION MAKING, 2005, 25 (03) :250-261
[3]   Comparison of anchor-based and distributional approaches in estimating important difference in common cold [J].
Barrett, Bruce ;
Brown, Roger ;
Mundt, Marlon .
QUALITY OF LIFE RESEARCH, 2008, 17 (01) :75-85
[4]   A taxonomy for responsiveness [J].
Beaton, DE ;
Bombardier, C ;
Katz, JN ;
Wright, JG .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (12) :1204-1217
[5]   Evaluating changes in health status: Reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders [J].
Beaton, DE ;
HoggJohnson, S ;
Bombardier, C .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (01) :79-93
[6]   Smallest real difference, a link between reproducibility and responsiveness [J].
Beckerman, H ;
Roebroeck, ME ;
Lankhorst, GJ ;
Becher, JG ;
Bezemer, PD ;
Verbeek, ALM .
QUALITY OF LIFE RESEARCH, 2001, 10 (07) :571-578
[7]   Quality of life in patients with Parkinson's disease [J].
Behari, A ;
Srivastava, AK ;
Pandey, RM .
PARKINSONISM & RELATED DISORDERS, 2005, 11 (04) :221-226
[8]   Progress in clinical neurosciences: Cognitive markers of progression in Alzheimer's disease [J].
Behl, P ;
Stefurak, TL ;
Black, SE .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2005, 32 (02) :140-151
[9]   How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure [J].
Brozek, Jan L. ;
Guyatt, Gordon H. ;
Schuenemann, Holger J. .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
[10]   Determinants of quality of life in Brazilian patients with Parkinson's disease [J].
Carod-Artal, Francisco Javier ;
Vargas, Antonio Pedro ;
Martinez-Martin, Pablo .
MOVEMENT DISORDERS, 2007, 22 (10) :1408-1415